Voyageur Pharmaceuticals (CVE:VM) Shares Up 47.4% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares traded up 47.4% during mid-day trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares changed hands during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Trading Up 47.4 %

The firm’s 50 day moving average is C$0.08 and its 200 day moving average is C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.